Login
Super Investors LeVasseur Capital Partners LLC
LC

LeVasseur Capital Partners LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$71.4M
Positions
8
Quarter ended
September 30, 2016
Filed
November 14, 2016

Reported portfolio value by quarter (12 quarters reported)

$120M $48.4M
Q4 13 Q3 14 Q2 15 Q1 16 Q3 16

$79.7M in Q4 2013 → $71.4M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2016. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
IM Ihs Markit Ltd 22.2% New 422,640 $15.9M
AT American Tower Corp New 20.4% Unchanged 128,513 $14.6M
FT Fleetcor Technologies Inc 15.5% Unchanged 63,675 $11.1M
Transdigm Group Inc 14.0% Unchanged 34,546 $9.99M
CS Computer Sciences Corp 9.6% New 131,149 $6.85M
Godaddy Inc 7.3% New 151,157 $5.22M
Comscore Inc 6.4% Unchanged 149,680 $4.59M
CC Charter Communications Inc New 4.5% New 12,015 $3.24M

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q3 2016

quarter ended September 30, 2016 · filed November 14, 2016

Company Action Shares changed Value of change % of portfolio
IM Ihs Markit Ltd New +422,640 +$15.9M 22.2%
I Ihs Inc Exited −118,833 −$13.7M —
Stericycle Inc Exited −96,707 −$10.1M —
CS Computer Sciences Corp New +131,149 +$6.85M 9.6%
Godaddy Inc New +151,157 +$5.22M 7.3%
CC Charter Communications Inc New New +12,015 +$3.24M 4.5%

Q2 2016

quarter ended June 30, 2016 · filed August 15, 2016

Company Action Shares changed Value of change % of portfolio
Stericycle Inc New +96,707 +$10.1M 16.7%
Comscore Inc New +149,680 +$3.57M 5.9%
VP Valeant Pharmaceuticals Intl Exited −128,269 −$3.37M —

Q1 2016

quarter ended March 31, 2016 · filed May 16, 2016

Company Action Shares changed Value of change % of portfolio
Equinix Inc Exited −39,088 −$11.8M —
VP Valeant Pharmaceuticals Intl Trimmed −128,269 −$3.37M 7.0%
Transdigm Group Inc Trimmed −15,177 −$3.34M 15.7%
I Ihs Inc Added +5,170 +$642K 30.5%
FT Fleetcor Technologies Inc Added +4,220 +$628K 19.6%
AT American Tower Corp New Added +5,840 +$598K 27.2%

Q4 2015

quarter ended December 31, 2015 · filed February 16, 2016

Company Action Shares changed Value of change % of portfolio
VP Valeant Pharmaceuticals Intl Added +94,144 +$9.57M 31.4%
Equinix Inc Trimmed −23,716 −$7.17M 14.2%
PS Platform Specialty Prods Cor Exited −404,748 −$5.12M —
Transdigm Group Inc Trimmed −15,857 −$3.62M 13.7%

Q3 2015

quarter ended September 30, 2015 · filed November 16, 2015

Company Action Shares changed Value of change % of portfolio
SH Solera Holdings Inc Exited −170,674 −$7.61M —
VP Valeant Pharmaceuticals Intl Trimmed −26,410 −$4.71M 29.8%
FT Fleetcor Technologies Inc Added +14,943 +$2.06M 8.4%
AT American Tower Corp New Added +21,050 +$1.85M 11.1%
PS Platform Specialty Prods Cor Added +66,500 +$841K 5.3%

Q2 2015

quarter ended June 30, 2015 · filed August 14, 2015

Company Action Shares changed Value of change % of portfolio
Equinix Inc Exited −78,570 −$18.3M —
Equinix Inc New +62,804 +$16M 13.3%
AT American Tower Corp New New +101,623 +$9.48M 7.9%
PS Platform Specialty Prods Cor New +338,248 +$8.65M 7.2%
FT Fleetcor Technologies Inc New +44,512 +$6.95M 5.8%
I Ihs Inc Trimmed −22,293 −$2.87M 12.2%
VP Valeant Pharmaceuticals Intl Trimmed −10,200 −$2.27M 35.0%
Transdigm Group Inc Trimmed −8,593 −$1.93M 12.3%
SH Solera Holdings Inc Trimmed −4,869 −$217K 6.3%

Q1 2015

quarter ended March 31, 2015 · filed May 15, 2015

No position changes this quarter.

Q4 2014

quarter ended December 31, 2014 · filed February 18, 2015

Company Action Shares changed Value of change % of portfolio
Verisign Inc Exited −167,953 −$9.26M —
SH Solera Holdings Inc New +175,543 +$8.98M 10.5%
Coty Inc Exited −231,764 −$3.84M —
I Ihs Inc Added +11,800 +$1.34M 18.1%
VP Valeant Pharmaceuticals Intl Added +8,600 +$1.23M 33.4%
Equinix Inc Added +2,563 +$581K 20.9%

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support